Michael Zinda - Mar 15, 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Science Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Mar 15, 2022
Transactions value $
-$6,023
Form type
4
Date filed
3/16/2022, 04:04 PM
Previous filing
Jan 20, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale -$6.02K -533 -1.14% $11.30 46K Mar 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.